Bioequivalence Evaluation of a Folate-Supplemented Oral Contraceptive Containing Ethinylestradiol/Drospirenone/Levomefolate Calcium versus Ethinylestradiol/Drospirenone and Levomefolate Calcium Alone

被引：2
作者：
Herbert Wiesinger
Urte Eydeler
Frank Richard
Dietmar Trummer
Hartmut Blode
Beate Rohde
Konstanze Diefenbach
机构：
[1] Bayer HealthCare Pharmaceuticals,
[2] Scope International GmbH,undefined
[3] Nycomed GmbH — A Takeda Company,undefined
来源：
Clinical Drug Investigation | 2012年 / 32卷
关键词：
Folate; Folate Level; Folate Status; Study Drug Administration; Drospirenone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Neural tube defects (NTDs) are congenital malformations that occur during early embryonic development. Suboptimal maternal folate status is a well-known risk factor for the occurrence of NTDs, and periconceptional folic acid supplementation has been shown to reduce the risk of NTDs. Folate-supplemented oral contraceptives (OCs) offer a means of improving folate status in women of childbearing potential by increasing their likelihood of having raised folate levels at the time of conception.
引用
收藏
页码：673 / 684
页数：11
相关论文
共 54 条
[1]  
Botto L.D.(1999)Neural-tube defects N Engl J Med 341 1509-19
[2]  
Moore C.A.(1991)MRC Vitamin Study Research Group Lancet 338 131-7
[3]  
Khoury M.J.(1992)Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation N Engl J Med 327 1832-5
[4]  
Czeizel A.E.(2010)Effects and safety of periconceptional folate supplementation for preventing birth defects Cochrane database of systematic reviews 10 CD007950-31
[5]  
Dudas I.(2009)Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 150 626-61
[6]  
De-Regil L.M.(2006)Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age Am J Clin Nutr 84 156-9
[7]  
Fernandez-Gaxiola A.C.(2007)Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age Am J Clin Nutr 86 1414-8
[8]  
Dowswell T.(2004)Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone Contraception 70 191-16
[9]  
Lamers Y.(2008)Folate and vitamin B12 metabolism: overview and interaction with riboflavin, vitamin B6, and polymorphisms Food Nutr Bull 29 S5-48
[10]  
Prinz-Langenohl R.(2010)Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics Clin Pharmacokinet 49 535-5
123456